F. Tassone, F. Broglio, L. Gianotti, E. Arvat, E. Ghigo and M. Maccario Pages 47 - 53 ( 7 )
The increasing prevalence of obesity has triggered intense research on its pharmacotherapy. Besides central neuroendocrine pathways, many peripheral endocrino-metabolic signals have been investigated, but only few are probably of some utility in weight loss. This review reports about ghrelin and other gastrointestinal peptides involved in hunger and satiety.
Ghrelin, glucagon-like peptide 1, cholecystokinin, bombesin, (3-36) peptide YY
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin,Corso Dogliotti 14, 10126 Turin, Italy.